Development and validation of Hebrew version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0

被引:0
作者
Ozeri, David [1 ]
Peretz, Shani [1 ]
Oppenheim, Amit [2 ]
Watad, Abdallah [3 ]
Lidar, Merav [4 ]
Braun-Moscovici, Yolanda [5 ]
机构
[1] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis,Internal Med A, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Internal Med A, Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis,Internal Med B, Tel Aviv, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis, Tel Aviv, Israel
[5] Technion Israel Inst Technol, Rheumatol Inst, Rappaport Fac Med, Haifa, Israel
关键词
Scleroderma; Hebrew; UCLA; GIT; gastrointestinal; instrument; SYSTEMIC-SCLEROSIS; RELIABILITY; VALIDITY;
D O I
10.1177/23971983221138712
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: The aim of this study was to test the reliability of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract (UCLA SCTC GIT) 2.0 questionnaire in Hebrew. Methods: UCLA SCTC GIT 2.0 was translated into Hebrew using the translation-retranslation method. The Hebrew version of the UCLA SCTC GIT 2.0 and the Hebrew version of the Short Form 36 (SF-36) were administered to 19 Hebrew-speaking patients with systemic sclerosis. Internal reliability was assessed using Cronbach's alpha. The Hebrew questionnaire was then tested for external validity using Spearman's correlation coefficient. Correlations (rho) <= 0.29 were considered small, 0.30 to 0.49 were moderate, and those > 0.50 were considered large. Differences were considered statistically significant at p < 0.05. Results: A group of 19 patients treated at Sheba Medical Center meeting the ACR/EULAR classification system for systemic sclerosis were included in the study. The mean age of the participants was 60.4 +/- 12 years with a female predominance (84%). Diffuse cutaneous scleroderma accounted for 10 of the participants (54%), 7 had limited cutaneous scleroderma (36%) with 2 having an overlap syndrome (10%). The Cronbach's alpha value for the UCLA SCTC GIT 2.0 scale was 0.908 showing reliability. In addition, the UCLA SCTC GIT 2.0 showed correlation to the SF-36. Conclusion: The translation of the Hebrew UCLA SCTC GIT 2.0 scale was reliable and valid with a total Cronbach's alpha score among the participants of 0.908. Cronbach's alpha was particularly reliable in reflux, bloating, social function, and emotional well-being. Our results suggest that our Hebrew version of the UCLA SCTC GIT 2.0 scale can be used as a tool in future studies with Hebrew-speaking patients. In the abstract conclusion, it states that "Cronbach's alpha was particularly reliable in reflux, bloating, social function, and emotional well-being." The related data should be listed in the results section and then an interpretation of the results should be listed in the conclusions section. Please revise.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 11 条
  • [1] Cultural Adaptation of Physical Activity Self-Report Instruments
    Arredondo, Elva M.
    Mendelson, Tamar
    Holub, Christina
    Espinoza, Nancy
    Marshall, Simon
    [J]. JOURNAL OF PHYSICAL ACTIVITY & HEALTH, 2012, 9 : S37 - S43
  • [2] Bae S, 2011, CLIN EXP RHEUMATOL, V29, pS15
  • [3] Gorga M, 2015, CLIN EXP RHEUMATOL, V33, pS61
  • [4] Gualtierotti R, 2015, CLIN EXP RHEUMATOL, V33, pS55
  • [5] Gualtierotti R., 2013, ANN RHEUM DIS, V72
  • [6] Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument
    Khanna, Dinesh
    Hays, Ron D.
    Park, Grace S.
    Braun-Moscovici, Yolanda
    Mayes, Maureen D.
    McNearney, Terry A.
    Hsu, Vivien
    Clements, Philip J.
    Furst, Daniel E.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (07): : 1280 - 1286
  • [7] Reliability and Validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
    Khanna, Dinesh
    Hays, Ron D.
    Maranian, Paul
    Seibold, James R.
    Impens, Ann
    Mayes, Maureen D.
    Clements, Philip J.
    Getzug, Terri
    Fathi, Nihal
    Bechtel, Amber
    Furst, Daniel E.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1257 - 1263
  • [8] Reliability and validity of the Korean version of the University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract instrument in patients with systemic sclerosis
    Lee, Tae Hee
    Lee, Joon Seong
    Park, Suyeon
    Lee, Kyung-Ann
    Kim, Hyun-Sook
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (06) : 1504 - +
  • [9] Validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0 in English- and Chinese-speaking patients in a multi-ethnic Singapore systemic sclerosis cohort
    Low, Andrea Hsiu Ling
    Xin, Xiaohui
    Law, Weng Giap
    Teng, Gim Gee
    Santosa, Amelia
    Lim, Anita
    Chan, Grace
    Ng, Swee Cheng
    Thumboo, Julian
    [J]. CLINICAL RHEUMATOLOGY, 2017, 36 (07) : 1643 - 1648
  • [10] Meijs J, 2014, CLIN EXP RHEUMATOL, V32, pS41